Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;1840(4):1313-30.
doi: 10.1016/j.bbagen.2013.10.033. Epub 2013 Oct 28.

The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Affiliations
Review

The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Romana Stark et al. Biochim Biophys Acta. 2014 Apr.

Abstract

Background: Plasma glucose levels are tightly regulated within a narrow physiologic range. Insulin-mediated glucose uptake by tissues must be balanced by the appearance of glucose from nutritional sources, glycogen stores, or gluconeogenesis. In this regard, a common pathway regulating both glucose clearance and appearance has not been described. The metabolism of glucose to produce ATP is generally considered to be the primary stimulus for insulin release from beta-cells. Similarly, gluconeogenesis from phosphoenolpyruvate (PEP) is believed to be the primarily pathway via the cytosolic isoform of phosphoenolpyruvate carboxykinase (PEPCK-C). These models cannot adequately explain the regulation of insulin secretion or gluconeogenesis.

Scope of review: A metabolic sensing pathway involving mitochondrial GTP (mtGTP) and PEP synthesis by the mitochondrial isoform of PEPCK (PEPCK-M) is associated with glucose-stimulated insulin secretion from pancreatic beta-cells. Here we examine whether there is evidence for a similar mtGTP-dependent pathway involved in gluconeogenesis. In both islets and the liver, mtGTP is produced at the substrate level by the enzyme succinyl CoA synthetase (SCS-GTP) with a rate proportional to the TCA cycle. In the beta-cell PEPCK-M then hydrolyzes mtGTP in the production of PEP that, unlike mtGTP, can escape the mitochondria to generate a signal for insulin release. Similarly, PEPCK-M and mtGTP might also provide a significant source of PEP in gluconeogenic tissues for the production of glucose. This review will focus on the possibility that PEPCK-M, as a sensor for TCA cycle flux, is a key mechanism to regulate both insulin secretion and gluconeogenesis suggesting conservation of this biochemical mechanism in regulating multiple aspects of glucose homeostasis. Moreover, we propose that this mechanism may be important for regulating insulin secretion and gluconeogenesis compared to canonical nutrient sensing pathways.

Major conclusions: PEPCK-M, initially believed to be absent in islets, carries a substantial metabolic flux in beta-cells. This flux is intimately involved with the coupling of glucose-stimulated insulin secretion. PEPCK-M activity may have been similarly underestimated in glucose producing tissues and could potentially be an unappreciated but important source of gluconeogenesis.

General significance: The generation of PEP via PEPCK-M may occur via a metabolic sensing pathway important for regulating both insulin secretion and gluconeogenesis. This article is part of a Special Issue entitled Frontiers of Mitochondrial Research.

Keywords: Anaplerosis; Gluconeogenesis; Insulin secretion; Mitochondrial GTP; PEPCK-M; Succinyl coenzyme A synthetase.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Glucose homeostasis
Plasma glucose levels are normally maintained within a relatively narrow range and are derived from three main sources: intestinal absorption, gluconeogenesis and glycogenolysis. Hormonal control is the most important mediator of plasma glucose. Acute glucoregulatory mechanisms that can affect plasma glucose levels within minutes involve insulin and glucagon. An increase in blood glucose levels provides the stimulus for insulin secretion. Insulin decreases blood glucose acutely by promoting tissue glucose uptake, followed by suppression of gluconeogenesis in both the liver and kidney as well as glycogenolysis in liver. A decrease in blood glucose levels results in the secretion of glucagon. Glucagon only acts on liver and stimulates glucose release, by initiating glycogenolysis. It does not act on the kidney.
Figure 2
Figure 2. Pyruvate and PEP cycling pathways
Pyruvate enters the mitochondrion via the pyruvate transporter (PT) and then enters the TCA cycle via the PDH-catalysed reaction that forms acetyl-CoA or via an anaplerotic reaction catalysed by PC. Several cycles have been proposed to account for the observed cycling of carbons to pyruvate which are following: Pyruvate-malate cycle (dark green): OAA is converted to malate and converted back to pyruvate via mitochondrial NAD-dependent or cytosolic NADP-dependent malic enzyme (ME). Malate exits the mitochondrion via the dicarboxylate carrier (DIC). Pyruvate-citrate cycle (orange): OAA is converted to citrate, which exits the mitochondrion via citrate/isocitrate carrier (CIC) and is converted to OAA and acetyl-CoA through citrate lyase (CL) reaction. Acetyl-CoA is converted to malonyl-CoA and long-chain acyl-CoA, while malate dehydrogenase (MDH) converts OAA into malate and further to pyruvate by cytosolic ME. Pyruvate-isocitrate cycle (light green): Citrate can be converted to isocitrate and exits the mitochondrion via CIC. In the cytosol isocitrate is converted to α-ketoglutarate by NADP-dependent isocitrate dehydrogenase (ICDc) which can then re-enter mitochondrial metabolism by α-ketoglutarate transporter (α-KGT). PEP cycle (red): OAA is converted to PEP by PEPCK-M and exits the mitochondrion via CIC or the adenine nucleotide transporter (ANT) (in exchange for ADP) in the inner mitochondrial membrane. PEP in the cytosol is converted to pyruvate by pyruvate kinase (PK).
Figure 3
Figure 3. Gluconeogenic substrates entering the gluconeogenic pathway
Graph shows entry point of gluconeogenic substrates, such as lactate, glycerol or amino acids. Both PEPCKs synthesize PEP from OAA that can feed the TCA cycle (anaplerosis) or serve for various biosynthetic processes (cataplerosis), such as gluconoegenesis. Alanine and glutamine are the main amino acids in the blood and arise during starvation from muscular protein breakdown (proteolysis). Likewise, fatty acids and glycerol are released from triglyceride breakdown (lipolysis) during fasting. Unlike glycerol, acetyl-CoA (fatty acid breakdown) does not contribute to cataplerotic OAA or PEP production or other gluconeogenic intermediates. Glycerol and glucose enter via glyceraldehyde 3-phosphate. Lactate forms in the muscle during anaerobic glycolysis and enters the gluconeogenic pathway via pyruvate and is the main gluconeogenic precursor in the kidney and liver.
Figure 4
Figure 4. Gluconeogenesis from Lactate
Lactate as substrate generates NADH via lactate dehydrogenase (LDH) in the cytosol necessary for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) reaction of gluconeognesis (orange). Mitochondrial oxaloacetate (OAA) has four pathways to cytosolic phosphoenolpyruvate (PEP), whereas three are energetically preferable for gluconeogenesis: The PEPCK-M pathway (red) is the most direct pathway and uses mtGTP produced by succinyl-CoA synthetase (SCS-GTP) in the TCA cycle. The PEPCK-C/aspartate pathway (blue) uses mitochondrial (mtAAT) and cytosolic (cytAAT) transamination reactions via aspartate aminotransferase (AAT) and needs shuttling of glutamate and α-ketoglutarate to generate OAA in the cytosol. OAA is converted by PEPCK-C that hydrolyses cytosolic GTP for the production of cytosolic PEP. The PEPCK-C/malate pathway (green) uses mitochondrial (mtMDH) and cytosolic (cytMDH) malate dehydrogenase (MDH). Mitochondrial MDH converts OAA in malate and malate is transferred to the cytosol, where cytosolic MDH forms OAA. This creates an excess NADH oxidized by the glycerol-3-phosphate shuttle.
Figure 5
Figure 5. (a) direct PEPCK-M pathway, (b) aspartate/PEPCK-C pathway, (c) malate/PEPCK-C pathway and (d) citrate/PEPCK-C pathway
Enzymes, transporters and metabolites involved in the 4 metabolic pathways from mitochondrial oxalacetate to cytosolic PEP. The charge valences of the metabolites that are used by the different transporters are listed as superscripts. The accounting is based on the number of protons equivalents generated (in green) or consumed (in red) by each of the metabolic steps. Synthesis of both ATP and GTP within the mitochondria was assumed to be equivalent to 3 protons, the transport of one ATP out of the mitochondria and glutamate into the mitochondria each consume one proton. Oxidation of mitochondrial NADH pumps 10 protons, while cytosolic translocates 6 via the glycerol-3-phosphate step since the malate aspartate shuttle is not available. Abbreviations: OAA, oxaloacetate; PEP, Phosphoenolpyruvate; CIC, citrate isocitrate transporter; DIC, dicarboxylate transporter; Asp, aspartate; αKG, α-ketoglutarate; Asp/Glu, aspartate glutamate transporter; αKGT, α-ketoglutarate transporter; ANT, adenine nucleotide transporter; Mal, malate; Glu, Glutamate; mtAAT, mitochondrial aspartate aminotransferase, cytAAT, cytosolic aspartate aminotransferase; mtMDH, mitochondrial malate dehydrogenase; cytMDH, cytosolic malate dehydrogenase, mtGlyc-3-PDH, mitochondrial glycerol 3 phosphate dehydrogenase; cytGlyc-3-PDH, cytosolic glycerol-3-phosphate dehydrogenase; NDPK, nucleotide diphosphokinase.
Figure 5
Figure 5. (a) direct PEPCK-M pathway, (b) aspartate/PEPCK-C pathway, (c) malate/PEPCK-C pathway and (d) citrate/PEPCK-C pathway
Enzymes, transporters and metabolites involved in the 4 metabolic pathways from mitochondrial oxalacetate to cytosolic PEP. The charge valences of the metabolites that are used by the different transporters are listed as superscripts. The accounting is based on the number of protons equivalents generated (in green) or consumed (in red) by each of the metabolic steps. Synthesis of both ATP and GTP within the mitochondria was assumed to be equivalent to 3 protons, the transport of one ATP out of the mitochondria and glutamate into the mitochondria each consume one proton. Oxidation of mitochondrial NADH pumps 10 protons, while cytosolic translocates 6 via the glycerol-3-phosphate step since the malate aspartate shuttle is not available. Abbreviations: OAA, oxaloacetate; PEP, Phosphoenolpyruvate; CIC, citrate isocitrate transporter; DIC, dicarboxylate transporter; Asp, aspartate; αKG, α-ketoglutarate; Asp/Glu, aspartate glutamate transporter; αKGT, α-ketoglutarate transporter; ANT, adenine nucleotide transporter; Mal, malate; Glu, Glutamate; mtAAT, mitochondrial aspartate aminotransferase, cytAAT, cytosolic aspartate aminotransferase; mtMDH, mitochondrial malate dehydrogenase; cytMDH, cytosolic malate dehydrogenase, mtGlyc-3-PDH, mitochondrial glycerol 3 phosphate dehydrogenase; cytGlyc-3-PDH, cytosolic glycerol-3-phosphate dehydrogenase; NDPK, nucleotide diphosphokinase.
Figure 5
Figure 5. (a) direct PEPCK-M pathway, (b) aspartate/PEPCK-C pathway, (c) malate/PEPCK-C pathway and (d) citrate/PEPCK-C pathway
Enzymes, transporters and metabolites involved in the 4 metabolic pathways from mitochondrial oxalacetate to cytosolic PEP. The charge valences of the metabolites that are used by the different transporters are listed as superscripts. The accounting is based on the number of protons equivalents generated (in green) or consumed (in red) by each of the metabolic steps. Synthesis of both ATP and GTP within the mitochondria was assumed to be equivalent to 3 protons, the transport of one ATP out of the mitochondria and glutamate into the mitochondria each consume one proton. Oxidation of mitochondrial NADH pumps 10 protons, while cytosolic translocates 6 via the glycerol-3-phosphate step since the malate aspartate shuttle is not available. Abbreviations: OAA, oxaloacetate; PEP, Phosphoenolpyruvate; CIC, citrate isocitrate transporter; DIC, dicarboxylate transporter; Asp, aspartate; αKG, α-ketoglutarate; Asp/Glu, aspartate glutamate transporter; αKGT, α-ketoglutarate transporter; ANT, adenine nucleotide transporter; Mal, malate; Glu, Glutamate; mtAAT, mitochondrial aspartate aminotransferase, cytAAT, cytosolic aspartate aminotransferase; mtMDH, mitochondrial malate dehydrogenase; cytMDH, cytosolic malate dehydrogenase, mtGlyc-3-PDH, mitochondrial glycerol 3 phosphate dehydrogenase; cytGlyc-3-PDH, cytosolic glycerol-3-phosphate dehydrogenase; NDPK, nucleotide diphosphokinase.
Figure 5
Figure 5. (a) direct PEPCK-M pathway, (b) aspartate/PEPCK-C pathway, (c) malate/PEPCK-C pathway and (d) citrate/PEPCK-C pathway
Enzymes, transporters and metabolites involved in the 4 metabolic pathways from mitochondrial oxalacetate to cytosolic PEP. The charge valences of the metabolites that are used by the different transporters are listed as superscripts. The accounting is based on the number of protons equivalents generated (in green) or consumed (in red) by each of the metabolic steps. Synthesis of both ATP and GTP within the mitochondria was assumed to be equivalent to 3 protons, the transport of one ATP out of the mitochondria and glutamate into the mitochondria each consume one proton. Oxidation of mitochondrial NADH pumps 10 protons, while cytosolic translocates 6 via the glycerol-3-phosphate step since the malate aspartate shuttle is not available. Abbreviations: OAA, oxaloacetate; PEP, Phosphoenolpyruvate; CIC, citrate isocitrate transporter; DIC, dicarboxylate transporter; Asp, aspartate; αKG, α-ketoglutarate; Asp/Glu, aspartate glutamate transporter; αKGT, α-ketoglutarate transporter; ANT, adenine nucleotide transporter; Mal, malate; Glu, Glutamate; mtAAT, mitochondrial aspartate aminotransferase, cytAAT, cytosolic aspartate aminotransferase; mtMDH, mitochondrial malate dehydrogenase; cytMDH, cytosolic malate dehydrogenase, mtGlyc-3-PDH, mitochondrial glycerol 3 phosphate dehydrogenase; cytGlyc-3-PDH, cytosolic glycerol-3-phosphate dehydrogenase; NDPK, nucleotide diphosphokinase.

Similar articles

Cited by

References

    1. Landau BR, et al. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest. 1996;98(2):378–85. - PMC - PubMed
    1. Cersosimo E, Garlick P, Ferretti J. Insulin regulation of renal glucose metabolism in humans. Am J Physiol. 1999;276(1 Pt 1):E78–84. - PubMed
    1. Meyer C, et al. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism. Am J Physiol. 1998;275(6 Pt 2):F915–21. - PubMed
    1. Jones JG, et al. Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease. Metabolic engineering. 2009;11(3):155–62. - PubMed
    1. Magnusson I, et al. Noninvasive tracing of Krebs cycle metabolism in liver. The Journal of biological chemistry. 1991;266(11):6975–84. - PubMed

Publication types

MeSH terms

  NODES
INTERN 2
twitter 2